Cancer News and Research

Latest Cancer News and Research

Salk Institute to establish Helmsley Center for Genomic Medicine

The Salk Institute for Biological Studies has received a $42 million gift-the largest in the Institute's history-to establish the Helmsley Center for Genomic Medicine (HCGM), a research center dedicated to decoding the common genetic factors underlying many complex chronic human diseases.

23 Jan 2013

Data from Provectus' PV-10 pre-clinical study on melanoma to be presented at AACR meeting

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces that data on PV-10 will be presented in a poster presentation at the American Association for Cancer Research Annual Meeting in Washington, DC.

23 Jan 2013

Interventional Radiology launches IR Quarterly magazine

Interventional Radiology announces the launch of IR Quarterly-a new magazine that communicates updates critical to the practice of interventional radiology, augmented with stories, interviews and in-depth analysis in each four-color, 40-page issue. IR Quarterly delivers quality reporting on political advocacy, practice management and the latest specialty news and information.

23 Jan 2013

SMO and AKT1 mutations appear to drive about 15% of meningiomas

Large-scale genomic sequencing has revealed two DNA mutations that appear to drive about 15 percent of brain tumors known as meningiomas, a finding that could lead to the first effective drug treatments for the tumors, report scientists from Dana-Farber Cancer Institute and the Broad Institute.

23 Jan 2013

Tumor separation surgery followed by SRS is safe and effective in controlling spinal metastases

Researchers from Memorial Sloan-Kettering Cancer Center (New York, NY) have found that tumor "separation surgery" followed by high-dose hypofractionated stereotactic radiosurgery (SRS) or high-dose single-fraction SRS is safe and effective in controlling spinal metastases regardless of the radiosensitivity of the particular tumor type that has invaded the spine.

23 Jan 2013

Trial to evaluate whether zolpidem reduces suicidal thinking in depressed insomniacs

Researchers want to know whether a sleeping pill reduces suicidal thoughts in depressed patients with insomnia.

23 Jan 2013

Exposure of human f-tal testicles to bisphenol A reduces testosterone production

Bisphenol A (BPA) is a chemical compound that is included in the composition of plastics and resins. It is used, for example, in the manufacture of food containers such as bottles and babies' feeding bottles. It is also found in the protective films used inside food and drink cans and on till receipts where it used as a discloser. Significant levels of BPA have also been found in human blood, urine, amniotic fluid and placentas.

23 Jan 2013

GeneDiagnostics, WILEX partner to commercialize serum HER-2/neu ELISA test in China

WILEX AG today announced that its US subsidiary WILEX Inc., Cambridge, MA, has entered into an exclusive distribution agreement with GeneDiagnostics Inc. for the commercialization of the serum HER-2/neu ELISA test in China.

23 Jan 2013

CD98hc molecule appears to be necessary for rapid and effective skin renewal

These mechanisms, described in vivo in mice, engage molecule CD98hc, which is involved in epidermis renewal and could be an indicator of the skin's capacity for regeneration.

23 Jan 2013

Study details exactly how Her2 gene promotes progression and spread of breast cancer cells

Research led by Dr. Suresh Alahari, the Fred Brazda Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans and its Stanley S. Scott Cancer Center, details exactly how the Her2 cancer gene promotes the progression and spread of breast cancer cells.

23 Jan 2013

Keeping healthy blood cells alive could help fight leukaemia

Instead of focusing on the elimination of cancer cells, maintaining a stable population of healthy blood cells in the bone marrow could be the most effective way to fight against leukaemia.

23 Jan 2013

Novel way to engineer specialized immune cells targeted by the AIDS virus

Researchers at the Stanford University School of Medicine have found a novel way to engineer key cells of the immune system so they remain resistant to infection with HIV, the virus that causes AIDS.

23 Jan 2013

Smoking cessation helps prevent cancer relapse after surgery

Lung and head and neck cancer patients who smoked before surgery are more likely to relapse than those who had quit before surgery, Moffitt Cancer Center researchers say. They found that smoking-relapse prevention interventions are needed immediately after surgery to help prevent relapse.

23 Jan 2013

Studies identify cellular pathways involved in governing day-night pattern of circadian rhythms

UC Irvine-led studies have revealed the cellular mechanism by which circadian rhythms - also known as the body clock - modify energy metabolism and also have identified novel compounds that control this action. The findings point to potential treatments for disorders triggered by circadian rhythm dysfunction, ranging from insomnia and obesity to diabetes and cancer.

23 Jan 2013

Galectin Therapeutics' GR-MD-02 reverses diabetic nephropathy in preclinical study

Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced new preclinical data on the efficacy of anti-galectin therapy on diabetic kidney disease.

23 Jan 2013

SV Bio, Mayo Clinic partner on whole genome diagnostics and interpretation

Mayo Clinic and Silicon Valley Biosystems (SV Bio) today announced a strategic collaboration for whole genome diagnostics and interpretation at the Mayo Clinic Center for Individualized Medicine and Mayo Medical Laboratories.

23 Jan 2013

Very low levels of BPS can disrupt natural estrogen hormone actions

A few years ago, manufacturers of water bottles, food containers, and baby products had a big problem. A key ingredient of the plastics they used to make their merchandise, an organic compound called bisphenol A, had been linked by scientists to diabetes, asthma and cancer and altered prostate and neurological development.

23 Jan 2013

SLU team discovers molecular pathway that contributes to triple-negative breast cancer

In research published in the Jan. 17 issue of The Journal of Cell Biology, a team led by Susana Gonzalo, Ph.D., assistant professor of biochemistry and molecular biology at Saint Louis University, has discovered a molecular pathway that contributes to triple-negative breast cancer, an often deadly and treatment resistant form of cancer that tends to strike younger women.

23 Jan 2013

Roundup: Ariz. Gov. proposing hospital tax for Medicaid expansion as Nev. ponders options; Vt. hospitals form ACO

Ariz. Gov. Jan Brewer, who has become something of a conservative icon for her aggressive opposition to Mr. Obama's policies, surprised many Legislature watchers at her State of the State address last week by saying she wanted to expand the state's Medicaid program to include anyone who makes up to 133 percent of the federal poverty level, or $14,856 for an individual.

23 Jan 2013

STA announces results from ABRAXANE plus gemcitabine phase III trial on pancreatic cancer

Australian biopharmaceutical company Specialised Therapeutics Australia announces that a phase III clinical trial of world leading breast cancer drug ABRAXANE (nanoparticle albumin-bound paclitaxel) in combination with current standard of care gemcitabine in patients with advanced pancreatic cancer has demonstrated substantially improved survival times, with double the number of patients surviving two years.

23 Jan 2013

Cancer News and Research

Latest Cancer News and Research

Salk Institute to establish Helmsley Center for Genomic Medicine

Data from Provectus' PV-10 pre-clinical study on melanoma to be presented at AACR meeting

Interventional Radiology launches IR Quarterly magazine

SMO and AKT1 mutations appear to drive about 15% of meningiomas

Tumor separation surgery followed by SRS is safe and effective in controlling spinal metastases

Trial to evaluate whether zolpidem reduces suicidal thinking in depressed insomniacs

Exposure of human f-tal testicles to bisphenol A reduces testosterone production

GeneDiagnostics, WILEX partner to commercialize serum HER-2/neu ELISA test in China

CD98hc molecule appears to be necessary for rapid and effective skin renewal

Study details exactly how Her2 gene promotes progression and spread of breast cancer cells

Keeping healthy blood cells alive could help fight leukaemia

Novel way to engineer specialized immune cells targeted by the AIDS virus

Smoking cessation helps prevent cancer relapse after surgery

Studies identify cellular pathways involved in governing day-night pattern of circadian rhythms

Galectin Therapeutics' GR-MD-02 reverses diabetic nephropathy in preclinical study

SV Bio, Mayo Clinic partner on whole genome diagnostics and interpretation

Very low levels of BPS can disrupt natural estrogen hormone actions

SLU team discovers molecular pathway that contributes to triple-negative breast cancer

Roundup: Ariz. Gov. proposing hospital tax for Medicaid expansion as Nev. ponders options; Vt. hospitals form ACO

STA announces results from ABRAXANE plus gemcitabine phase III trial on pancreatic cancer

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Newsletters you may be interested in